FDA NDC Directory · JSON-LD · Markdown

neostigmine methylsulfate

NDC 31722-995 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerCamber Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212512
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNEOSTIGMINE METHYLSULFATE (1 mg/mL)
Marketing started20210104
Package count1

External sources

Source: openFDA. Public-domain (CC0).